Director/PDMR Shareholding

RNS Number : 6485Q

GlaxoSmithKline PLC

20 February 2019

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr J Ford
b)	Position/status	SVP & General Counsel
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	GlaxoSmithKline plc American Depositary Shares ('ADSs') ISIN: US37733W1053
b)	Nature of the transaction	The exercise of options over 11,870 ADSs, granted on 22 February 2010 under the GlaxoSmithKline Share Option Plan, at an option price of $37.32.
c)	Price(s) and volume(s)	Price(s) Volume(s) $37.32 2,679 (Incentive Stock Option) $37.32 9,191 (Non-Qualified Stock Option)
d)	Aggregated information Aggregated volume Price	11,870 $37.32
e)	Date of the transaction	2019-02-19
f)	Place of the transaction	n/a

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr J Ford
b)	Position/status	SVP & General Counsel
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	GlaxoSmithKline plc American Depositary Shares ('ADSs') ISIN: US37733W1053
b)	Nature of the transaction	The sale of 11,870 ADSs, granted on 22 February 2010 under the GlaxoSmithKline Share Option Plan.
c)	Price(s) and volume(s)	Price(s) Volume(s) $41.22 2,679 (Incentive Stock Option) $41.22 9,191 (Non-Qualified Stock Option)
d)	Aggregated information Aggregated volume Price	11,870 $41.22
e)	Date of the transaction	2019-02-19
f)	Place of the transaction	New York Stock Exchange (XNYS)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr J Ford
b)	Position/status	SVP & General Counsel
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	GlaxoSmithKline plc American Depositary Shares ('ADSs') ISIN: US37733W1053
b)	Nature of the transaction	The sale of ADSs
c)	Price(s) and volume(s)	Price(s) Volume(s) $41.22 11,884
d)	Aggregated information Aggregated volume Price	n/a (single transaction)
e)	Date of the transaction	2019-02-19
f)	Place of the transaction	New York Stock Exchange (XNYS)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr J Ford
b)	Position/status	SVP & General Counsel
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Sale of Ordinary Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) £15.66 1
d)	Aggregated information Aggregated volume Price	n/a (single transaction)
e)	Date of the transaction	2019-02-19
f)	Place of the transaction	London Stock Exchange (XLON)

 

END

 

 

DSHZBLFLKLFXBBK